{"id":10014,"date":"2025-08-29T21:34:52","date_gmt":"2025-08-29T19:34:52","guid":{"rendered":"https:\/\/aliber.org\/web\/?p=10014"},"modified":"2025-08-29T21:34:52","modified_gmt":"2025-08-29T19:34:52","slug":"%f0%9d%90%80%f0%9d%90%8b%f0%9d%90%88%f0%9d%90%81%f0%9d%90%84%f0%9d%90%91-%f0%9d%90%9c%f0%9d%90%a8%f0%9d%90%a7%f0%9d%90%ac%f0%9d%90%a8%f0%9d%90%a5%f0%9d%90%a2%f0%9d%90%9d%f0%9d%90%9a-%f0%9d%90%9e","status":"publish","type":"post","link":"https:\/\/aliber.org\/web\/2025\/08\/29\/%f0%9d%90%80%f0%9d%90%8b%f0%9d%90%88%f0%9d%90%81%f0%9d%90%84%f0%9d%90%91-%f0%9d%90%9c%f0%9d%90%a8%f0%9d%90%a7%f0%9d%90%ac%f0%9d%90%a8%f0%9d%90%a5%f0%9d%90%a2%f0%9d%90%9d%f0%9d%90%9a-%f0%9d%90%9e\/","title":{"rendered":"\ud835\udc00\ud835\udc0b\ud835\udc08\ud835\udc01\ud835\udc04\ud835\udc11 \ud835\udc1c\ud835\udc28\ud835\udc27\ud835\udc2c\ud835\udc28\ud835\udc25\ud835\udc22\ud835\udc1d\ud835\udc1a \ud835\udc1e\ud835\udc25 \ud835\udc29\ud835\udc25\ud835\udc1a\ud835\udc27 \ud835\udc1d\ud835\udc1e \ud835\udc1a\ud835\udc1c\ud835\udc1c\ud835\udc22\ud835\udc28\u0301\ud835\udc27 \ud835\udc29\ud835\udc1a\ud835\udc2b\ud835\udc1a \ud835\udc1e\ud835\udc25 \ud835\udc1c\ud835\udc2e\ud835\udc1a\ud835\udc2b\ud835\udc2d\ud835\udc28 \ud835\udc2d\ud835\udc2b\ud835\udc22\ud835\udc26\ud835\udc1e\ud835\udc2c\ud835\udc2d\ud835\udc2b\ud835\udc1e \ud835\udc1d\ud835\udc1e \ud835\udfd0\ud835\udfce\ud835\udfd0\ud835\udfd3 \ud835\udc32 \ud835\udc29\ud835\udc2b\ud835\udc28\ud835\udc32\ud835\udc1e\ud835\udc1c\ud835\udc2d\ud835\udc1a \ud835\udc1e\ud835\udc2c\ud835\udc2d\ud835\udc2b\ud835\udc1a\ud835\udc2d\ud835\udc1e\ud835\udc20\ud835\udc22\ud835\udc1a\ud835\udc2c \ud835\udc29\ud835\udc1a\ud835\udc2b\ud835\udc1a \ud835\udfd0\ud835\udfce\ud835\udfd0\ud835\udfd4"},"content":{"rendered":"<p>La <strong>Alianza Iberoamericana de Enfermedades Raras<\/strong> (ALIBER) avanza hacia el final de 2025 con un plan de acci\u00f3n consolidado y la mirada puesta en el pr\u00f3ximo a\u00f1o. En una reuni\u00f3n reciente, su Junta Directiva revis\u00f3 los logros alcanzados y defini\u00f3 los pasos a seguir, poniendo el acento en c\u00f3mo sostener y amplificar el trabajo de la red en toda la regi\u00f3n.<\/p>\n<p>El encuentro no se limit\u00f3 a evaluar lo hecho. Los directivos coincidieron en que muchos de los objetivos previstos para este a\u00f1o ya deber\u00edan estar cumplidos, por lo que <strong>el desaf\u00edo ahora es asegurar que cada meta quede firmemente encarrilada y pueda sostenerse en el tiempo.<\/strong><\/p>\n<p>Uno de los puntos destacados fue la <strong>relaci\u00f3n con sponsors y aliados estrat\u00e9gicos<\/strong>.<\/p>\n<p>ALIBER busca que este v\u00ednculo vaya m\u00e1s all\u00e1 del apoyo financiero, <strong>apuntando a construir sinergias que permitan desarrollar proyectos de mayor alcance e impacto en el \u00e1mbito iberoamericano.<\/strong><\/p>\n<p>La organizaci\u00f3n reafirm\u00f3 tambi\u00e9n su aspiraci\u00f3n de <strong>consolidarse como la red m\u00e1s amplia de la regi\u00f3n en el acompa\u00f1amiento a personas y familias que conviven con enfermedades raras.<\/strong><\/p>\n<p>En este sentido, la agenda para 2026 contempla un <strong>rol m\u00e1s activo en advocacy e incidencia pol\u00edtica<\/strong>, mediante la organizaci\u00f3n de foros que refuercen la visibilidad de estas patolog\u00edas en los espacios de decisi\u00f3n p\u00fablica.<\/p>\n<p>Adem\u00e1s, de priorizar tambi\u00e9n el <strong>fortalecimiento del Servicio de Informaci\u00f3n y Orientaci\u00f3n<\/strong>, con el fin de ampliar su alcance y mejorar la capacidad de respuesta hacia pacientes y familias, reforzando as\u00ed su papel como un espacio de referencia y apoyo en Iberoam\u00e9rica.<\/p>\n<p><strong><em>Con estas acciones, ALIBER busca dar continuidad a los avances logrados en 2025 y proyectar una estrategia de futuro orientada a maximizar el impacto colectivo y garantizar un acceso m\u00e1s equitativo a los servicios de salud en toda la regi\u00f3n.<\/em><\/strong><\/p>\n<p><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter wp-image-10015 size-full\" src=\"https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/08\/costa-rica.jpeg\" alt=\"\" width=\"918\" height=\"1398\" srcset=\"https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/08\/costa-rica.jpeg 918w, https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/08\/costa-rica-197x300.jpeg 197w, https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/08\/costa-rica-672x1024.jpeg 672w, https:\/\/aliber.org\/web\/wp-content\/uploads\/2025\/08\/costa-rica-768x1170.jpeg 768w\" sizes=\"(max-width: 918px) 100vw, 918px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>La Alianza Iberoamericana de Enfermedades Raras (ALIBER) avanza hacia el final de 2025 con un plan de acci\u00f3n consolidado y la mirada puesta en el pr\u00f3ximo a\u00f1o. En una reuni\u00f3n<a href=\"https:\/\/aliber.org\/web\/2025\/08\/29\/%f0%9d%90%80%f0%9d%90%8b%f0%9d%90%88%f0%9d%90%81%f0%9d%90%84%f0%9d%90%91-%f0%9d%90%9c%f0%9d%90%a8%f0%9d%90%a7%f0%9d%90%ac%f0%9d%90%a8%f0%9d%90%a5%f0%9d%90%a2%f0%9d%90%9d%f0%9d%90%9a-%f0%9d%90%9e\/\">[&#8230;]<\/a><\/p>\n","protected":false},"author":1,"featured_media":10015,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[2,138],"tags":[],"class_list":["post-10014","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-aliber","category-noticias"],"_links":{"self":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts\/10014","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/comments?post=10014"}],"version-history":[{"count":1,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts\/10014\/revisions"}],"predecessor-version":[{"id":10016,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/posts\/10014\/revisions\/10016"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/media\/10015"}],"wp:attachment":[{"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/media?parent=10014"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/categories?post=10014"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aliber.org\/web\/wp-json\/wp\/v2\/tags?post=10014"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}